Interparfums financials
$115.09−2.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $341.0M | $344.9M | $386.2M | $429.6M | $333.9M | $338.8M | $361.5M | $424.6M | $342.2M | $324.0M | $328.7M | $368.0M |
| Gross profit | $223.5M | $224.6M | $237.3M | $272.8M | $221.1M | $216.0M | $233.0M | $271.2M | $220.8M | $202.4M | $212.7M | $235.0M |
| Gross margin | 65.5% | 65.1% | 61.5% | 63.5% | 66.2% | 63.7% | 64.5% | 63.9% | 64.5% | 62.5% | 64.7% | 63.9% |
| Operating income | $48.9M | $74.1M | $27.5M | $108.6M | $59.2M | $75.1M | $36.0M | $106.0M | $64.8M | $68.0M | $18.9M | $87.2M |
| Net income | $30.5M | $43.4M | $28.1M | $65.8M | $32.0M | $42.5M | $24.2M | $62.3M | $36.8M | $41.0M | $10.4M | $53.2M |
| Net margin | 8.9% | 12.6% | 7.3% | 15.3% | 9.6% | 12.5% | 6.7% | 14.7% | 10.8% | 12.7% | 3.2% | 14.5% |
| Diluted EPS | $0.95 | $1.35 | $0.88 | $2.05 | $0.99 | $1.32 | $0.76 | $1.93 | $1.14 | $1.27 | $0.32 | $1.66 |
| EBITDA | $54.8M | $79.9M | $34.0M | $115.1M | $65.5M | $81.0M | $50.2M | $112.2M | $70.8M | $74.0M | $18.9M | $91.6M |
| Operating cash flow | $45.6M | $85.0K | $146.5M | $63.9M | $11.9M | -$7.4M | $138.0M | $76.1M | $25.5M | -$52.0M | $81.5M | $17.5M |
| Free cash flow | $44.6M | -$1.3M | $145.0M | $57.6M | -$3.3M | -$8.8M | $136.1M | $75.4M | $24.4M | -$53.0M | $79.6M | $16.1M |
| Diluted shares | 32.0M | 32.0M | 32.1M | 32.1M | 32.1M | 32.2M | 31.7M | 32.3M | 32.3M | 32.3M | 32.1M | 32.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $169.7M | $79.9M | $158.1M | $110.4M | $151.5M | $96.6M |
| Short-term investments | $41.6M | $157.2M | $137.1M | $77.5M | $53.9M | $75.3M |
| Total debt | $145.7M | $161.9M | $185.4M | $206.3M | $254.4M | $158.4M |
| Total assets | $1.49B | $1.54B | $1.59B | $1.56B | $1.56B | $1.44B |
| Total liabilities | $399.4M | $430.2M | $481.2M | $460.2M | $505.0M | $433.0M |
| Shareholders' equity | $1.09B | $1.11B | $1.10B | $1.10B | $1.06B | $1.01B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology